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During the industrial scale-up of bioprocesses it is important to establish that the biological systemhas not changed significantlywhen
moving from small laboratory-scale shake flasks or culturing bottles to an industrially relevant production level. Therefore, during
upscaling of biomass production for a range ofmetal transformations, including the production of biogenicmagnetite nanoparticles
byGeobacter sulfurreducens, from 100-ml bench-scale to 5-liter fermentors, we applied Fourier transform infrared (FTIR) spec-
troscopy as a metabolic fingerprinting approach followed by the analysis of bacterial cell extracts by gas chromatography-mass
spectrometry (GC-MS) for metabolic profiling. FTIR results clearly differentiated between the phenotypic changes associated
with different growth phases as well as the two culturing conditions. Furthermore, the clustering patterns displayed by multivar-
iate analysis were in agreement with the turbidimetric measurements, which displayed an extended lag phase for cells grown in a
5-liter bioreactor (24 h) compared to those grown in 100-ml serum bottles (6 h). GC-MS analysis of the cell extracts demon-
strated an overall accumulation of fumarate during the lag phase under both culturing conditions, coinciding with the detected
concentrations of oxaloacetate, pyruvate, nicotinamide, and glycerol-3-phosphate being at their lowest levels compared to other
growth phases. These metabolites were overlaid onto a metabolic network of G. sulfurreducens, and taking into account the lev-
els of thesemetabolites throughout the fermentationprocess, the limitedavailabilityofoxaloacetate andnicotinamidewould seemtobe
themainmetabolicbottleneckresulting fromthis scale-upprocess.Additionalmetabolite-feedingexperimentswerecarriedout tovalidate
theabovehypothesis.Nicotinamide supplementation (1mM)didnotdisplayanysignificant effectson the lagphaseofG. sulfurreducens
cells grown in the 100-ml serum bottles. However, it significantly improved the growth behavior of cells grown in the 5-liter bio-
reactor by reducing the lag phase from 24 h to 6 h, while providing higher yield than in the 100-ml serum bottles.
Geobacter species are Gram-negative deltaproteobacteria,which have been recognized as an intrinsic component of a
diverse range of natural subsurface environments, including soils
and groundwater, as well as aquatic sediments (1). Geobacter spe-
cies are considered to play a vital role in the global recycling of
metals and carbon (2) in anaerobic environments, coupling the
oxidation of acetate, and other key intermediates from fermenta-
tive metabolism of natural complex organic matter, to the reduc-
tion of Fe(III) and other metals (3, 4). G. metallireducens was the
first organism with the ability of reducing insoluble Fe(III) oxides
in tandem with oxidation of acetate to be isolated (5, 6).
G. sulfurreducens strain PCA is another member of the family
Geobacteraceae, which also has the ability of coupling the oxida-
tion of acetate to the reduction of sulfur, fumarate, Fe(III), and
othermetals (7). The availability of its complete genome sequence
revealed not only unexpected insights into its complex metabo-
lism (including evidence of aerobic metabolism [8] and one-car-
bon and complex carbon metabolism) but also multiple capabil-
ities in terms of motility and chemotactic behavior (2). For a
detailed introduction to both the physiology and ecology of Geo-
bacter spp. (and other metal reducers), see reference 9.
It is perhaps not surprising that thesemultiple and complexmet-
abolic and physiological capabilities make this fascinating species an
ideal candidate for bioremediation applications (among others). Of
particular interest is the treatment and removal of subsurface metal
contaminants (10, 11), such as U(VI) (12, 13), Cr(VI) (14), and Tc-
(VII) (15, 16). For a comparative reviewof themicrobial reductionof
metals and metalloids, see reference 17, and for a recent review of
systems-level and modeling approaches to bioremediation of urani-
um-contaminated groundwater, see reference 18.
Other related biotechnical applications linked to Geobacter
species include the production of magnetite nanoparticles (19–
21) and the potential role of thismagneticmaterial in a wide range
of applications such as cancer therapy (22), drug delivery (23),
bioseparation (24, 25), catalysis (26), reductive bioremediation of
contaminants (J. M. Byrne, H. Muhamadali, V. S. Coker, J. Coo-
per, and J. R. Lloyd, submitted for publication), and the produc-
tion of nanomaterials for magnetic data storage devices (28).
However, the ability to exploit these microorganisms to their full
potential requires a deeper understanding of the basis of their
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biochemical composition, genetics, and metabolic behavior in a
range of process environments (29), especially at scale.
There are a range of approaches available to optimize the bio-
technological potential of bacteria, such as genetic modification
and adjustment of medium components and/or incubation con-
ditions, any of which could be applied to improve, for example,
the growth kinetics and yields of these extremely useful microor-
ganisms, particularly when there is a requirement to scale up for
industrial/biotechnological applications. Here, we demonstrate a
metabolomics approach for achieving this goal.
The metabolome is described as being the complement of all
low-molecular-weightmetabolites found within a biological sam-
ple, such as a single organism, which encompasses the end prod-
ucts of gene expression that are necessary for the maintenance,
growth, and normal function of a cell (i.e., metabolic intermedi-
ates, signaling molecules, and secondary metabolites) (30). The
field of metabolomics is accelerating at a considerable rate, which
is perhaps not surprising considering improvements in the ability
tomeasure multiple metabolites from complex biological systems
with a high degree of accuracy and precision (31).
Since the metabolome is downstream from the genome, pro-
teome, and transcriptome in biological systems and is affected via
the changes and interactions of the above-described processes, it is
said to reflect the activities of the cells at functional levels (32).
Therefore, metabolomic approaches are considered complemen-
tary to genomics, transcriptomics, and proteomics (33) and have
been used for optimizing microbial processes (34–36).
Metabolic fingerprinting is generally employed as a rapid,
global, and high-throughput approach to provide sample classifi-
cation and is also used as a screening tool to discriminate samples
of different biological status (37) (such as the physiological state in
this case) or origin, which may pertain to disease diagnostics
(case-control) or longitudinal intervention, both aimed at bio-
marker discovery (38, 39).
Fourier transform infrared (FTIR) spectroscopy is a vibra-
tional spectroscopy technique based on the principle of the ab-
sorption of infrared light by the sample of interest, causing inter-
molecular bond vibrations, which can be detected and directly
correlated to (bio)chemical species. FTIR, in comparison to other
metabolic fingerprinting techniques, offers the advantages ofmin-
imal sample preparation, high-throughputmicrobial analysis, ex-
treme rapidity (spectral acquisition, 10 s to 1min), high reproduc-
ibility, low cost, and portability. Since its potential for microbial
analysis was first widely recognized by Naumann et al. (40), FTIR
has been applied to a wide range of areas within microbiology
(40), including clinical (41, 42), food (43–45), environmental
(46–49), and biotechnological (50) applications.
While FTIR spectroscopy is a global, holistic approach, it does
not of course have the sensitivity or specificity of mass spectrom-
etry (MS) approaches. Therefore, in this study, we also employed
gas chromatography-MS (GC-MS) as a metabolic profiling
method which yields information on central carbon as well as
amino acid metabolism (51) and has been used to analyze indus-
trial bioprocesses and aid in metabolic engineering (34, 36).
This study was focused on the first part of a two-step biomag-
netite nanoparticle production processwhich includes (i) biomass
production and (ii) magnetite nanoparticle production (19, 52).
The aim was to understand and extend our current knowledge
regarding the complex metabolic potential of Geobacter species
specifically at different stages of batch culture growth in contrast-
ing serum bottle and bioreactor studies. If successful, this would
support, aid, and potentially improve the industrial scale-up of
biomass production for a range of Geobacter-specific biotechno-
logical processes, most notably nanomagnetite production.
MATERIALS AND METHODS
Media and growth conditions. G. sulfurreducens strain PCA was used in
this study and cultivated under anoxic conditions at 30°C in a modified
fresh water medium (NBAF) (53), which is described in Table S1 in the
supplemental material.
For assessing potential differences in the metabolic state during
growth at contrasting scales, two different batch volumes were used: 100
ml (in 120-ml serum bottles, in triplicate) and 5 liters (in a 7-liter
Applikon dish-bottom reactor vessel; Applikon Biotechnology., Glouces-
tershire, United Kingdom) (see Fig. S1 in the supplemental material).
Both volumes were inoculated with 10% (vol/vol) late-log-phase G. sul-
furreducens, followed by incubation under anoxic conditions for 7 days at
30°C.NBAFwas also used for the inoculumpreparation step following the
standard protocol. The same batch of medium and starting inoculumwas
used to start the experiment for both incubation conditions in order to
reduce any potential variation.
At each time point, three 100-ml serum bottles were sacrificed to
achieve sufficient biomass for GC-MS, FTIR, and optical density (OD)
analysis. Aliquots (50 ml) were taken at 13 different time points: 0, 6, 12,
18, 24, 36, 48, 60, 72, 96, 120, 144, and 168 h. A fraction (15 ml) of the
collected samples were quenched and used for GC-MS analysis, and
the remaining (35 ml) were employed for FTIR analysis. The ODs of the
samples were also recorded at 600 nm to monitor the growth of the or-
ganism during the incubation period.
FTIR. (i) Sample preparation. Biomass was collected for FTIR analy-
sis by centrifuging 35 ml of collected samples for 20 min at 5,240  g at
4°C. The supernatant was removed, and the cell pellets were washed twice
with 5 ml of sterile 0.9% (wt/vol) saline solution, followed by 10 min of
centrifugation at 5,240 g at 4°C. After the final washing step, the super-
natant was removed and the pellets were flash frozen in liquid nitrogen for
1 min and stored at80°C. Prior to analysis, all samples were thawed on
ice and biomass loadings normalized according toODat 600 nm (OD600).
A Bruker 96-well silicon sampling plate (Bruker Ltd., Coventry,
United Kingdom) was washed three times with 5% sodium dodecyl sul-
fate (SDS) solution and twice with 70% ethanol and finally rinsed three
times with deionized water and dried at 55°C. Samples were spotted ran-
domly in triplicates as 20-l aliquots onto an FTIR silicon plate and dried
via heating for 30min in an oven at 55°C in order to remove asmuchwater
as possible and fix the samples to the plate.
(ii) Instrument setup. All FTIR bacterial spectra were collected in
transmissionmode on a Bruker Equinox 55 infrared spectrometer follow-
ing previously published methods (54). All spectra were recorded in the
mid-infrared range between 4,000 and 600 cm1 wavenumbers, and these
were acquired at a resolution of 4 cm1, with 64 spectral coadds to im-
prove the signal-to-noise ratio.
(iii) Data analysis. FTIR spectra were analyzed using MATLAB ver-
sion 9 (The MathWorks Inc., Natick, MA). In order to compensate for
small unavoidable sample size differences, the spectra were scaled using
the extended multiplicative signal correction (EMSC) method (55). CO2
vibrations (2,400 to 2,275 cm1) were then removed from spectra and
filled with a trend.
Principal component analysis (PCA) (56) and discriminant function
analysis (DFA) were used for the statistical analysis of the preprocessed
data. PCA is an unsupervised clustering method with the aim of reducing
the dimensionality of a data set, without a priori knowledge of any group-
ings in the data, by decomposing it into new variables that are linear
combinations of the original data. PC-DFA is a supervised method which
discriminates the data into groups on the basis of PCs and a priori knowl-
edge of the experimental class structure; PC-DFA functions by minimiz-
ing within-group variance while maximizing between-group variance
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(57). Comparison of intensities of different FTIR spectral regions (se-
lected based on PC-DFA loadings) was carried out as follows: FTIR raw
spectra of the appropriate samples were baseline corrected, followed by
plotting the intensity (peak height to baseline) of each peak against time.
GC-MS analysis. (i) Quenching and extraction. The 15-ml sample
aliquots collected as described abovewere immediately quenched in 30ml
of 60% aqueous methanol (48°C), followed immediately by centrifuga-
tion at 9°C for 10 min at 5,000  g using a Sigma 6K15 centrifuge
(Sigma-Aldrich, Dorset, United Kingdom). The supernatant was re-
moved and cell pellets flash frozen in liquid nitrogen and stored at80°C
for further analysis (58).
Extractionwas carried out by suspending the biomass in 0.5ml of 80%
methanol (48°C), followed by snap-freezing in liquid nitrogen and
thawing on ice. The freeze-thaw cycle was performed a total of three times
to maximize the recovery of the intracellular metabolites. Extracts were
then centrifuged at 15,871  g for 5 min at 9°C. The supernatant was
removed to a new sterile microcentrifuge tube and kept on dry ice while a
second round of extraction using 0.5 ml of 80% methanol (48°C) was
carried out on the pellets following the steps described above. The second
set of extracts (0.5 ml) was combined with the first set and normalized
using 80%methanol according to the OD600 of each sample, followed by
combining 50 l from each of the samples in a new tube as the quality
control (QC) sample (59). One hundred microliters of internal standard
solution (0.2 mg ml1 succinic-d4 acid, 0.2 mg ml
1 glycine-d5, 0.2 mg
ml1 benzoic-d5 acid, and 0.2 mg ml
1 lysine-d4) was added to all sam-
ples, and the samples were dried by speed vacuum concentration at 30°C
for 12 h (concentrator 5301; Eppendorf, Cambridge, United Kingdom)
prior to being stored at80°C until further analysis.
(ii) Derivatization. Derivatization followed a two-step procedure of
methoxyamination followed by trimethylsilylation as described precisely
by Wedge et al. (60).
(iii) GC-MS setup. GC-MS analysis was carried out using an Agilent
(Wokingham, United Kingdom) 6890N GC oven coupled to a Pegasus III
mass spectrometer (Leco, St. Joseph, MI, USA), following previously pub-
lished methods (60–62). All initial identifications adhered to minimumme-
tabolite reporting standards (63) by providing quality assurance of data and
removingmass spectral features withinQC samples with high deviation. The
final output from this procedure was a matrix of retention time versus mass
data with related metabolite identities and peak areas linked to each sample
injection. This data set was then used for statistical analysis.
(iv) Data analysis. A total number of 104 unique GC-MS peaks were
detected. Variables with more than 50% missing values were removed
(64), resulting in a total of 67 peaks remaining. Peak areas of these peaks
were first log10 scaled then subjected to PC-DFA. In addition, canonical
correlation analysis (CCA) was also applied to gain a better view of the
changes associated with time in the metabolic profiles measured by GC-
MS. CCA is a commonly used statistical method to measure the correla-
tion between two sets of random variables (65). In this study, we used
CCA to measure the correlation between the GC-MS data and the corre-
sponding time of incubation.
RESULTS AND DISCUSSION
There has been an increasing interest in the biotechnological ex-
ploitation of Geobacter species for a range of applications, includ-
ing the formation of biomagnetite nanoparticles via the enzymatic
reduction of Fe(III) oxyhydroxides. One particular challenge that
needs to be addressed for successful commercial exploitation is
the scalable production of biomass that is active against the Fe(III)
precursor to magnetite. To date few studies have addressed the
physiological state ofGeobacter or other Fe(III)-reducing bacterial
species in different bioreactor configurations, especially during
scale-up. In this series of experiments, the goal was to assess the
changes in growth behavior and metabolism of G. sulfurreducens
cells associated with the scale-up of biomass production through
monitoring growth (OD measurements), measuring metabolic
fingerprints using FTIR, and generating metabolic profiles using
GC-MS. In a parallel study (Byrne et al., submitted), which will be
reported elsewhere, the surface reactivity, magnetic properties,
and particle size distribution of the biomagnetite nanoparticles
generated from 100-ml serum bottles and 5- and 50-liter bioreac-
tors (under the same growth conditions) were compared and re-
ported to be at comparable levels. However, during scaling up
from serumbottles to fermentors, a prolonged lag phase occurred,
extending the incubation period and potentially making the pro-
cess less efficient and commercially attractive; hence, cellular me-
tabolism is explored in detail here to identify the bottleneck and
restore adequate cellular growth behavior.
FIG 1 Growth curves ofG. sulfurreducens grown on NBAF at 30°C for 168 h in 100-ml serum bottles (red line) and in a 5-liter bioreactor with (green line) and
without (blue line) nicotinamide supplementation. Relative peak areas (normalized to an internal standard) of nicotinamide in the medium (purple line)
detected by GC-MS in the 5-liter bioreactor supplementation experiment are plotted against the sampling time. The time point measurements for the serum
bottles are means of three biological replicates with error bars indicating the standard deviation. Single measurements were recorded for the bioreactor samples
due to volume constraint.
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Growth profiles. Figure 1 shows the growth kinetics of G. sul-
furreducens in NBAF at 30°C during a 7-day incubation period. A
typical three-phase (lag, exponential, and stationary) growth pat-
ternwas observed, with similar final cell densities for both scales of
batch cultures. However, increasing the vessel volume prolonged
the lag phase significantly: cells grown in 100-ml serum bottles
exhibited a 6-h lag phase, while the lag phase of the bioreactor-
grown cells was24 h.
FTIR metabolic fingerprinting. As microbial cells multiply
and bacterial cultures proceed through their distinctive and well-
documented growth phases, changes also occur in the distribution
and composition of biochemical components within the cells
(e.g., proteins, lipids, polysaccharides, and nucleic acids), which
are not detectable by some conventional techniques such as OD
measurement and bacterial plate counts. However, FTIR can re-
veal these changes by detecting different functional groups
through molecular bond vibrations and recording them as spec-
tral features, which can then be analyzed by a variety of multivar-
iate statistical methods (66).
FTIR spectra collected in this study were preprocessed and
analyzed using PC-DFA. The scores plot of all samples together
(Fig. 2) display a gradual phenotypic change appearing in the G.
sulfurreducens cells during the incubation period in both the
100-ml serum bottles and the larger 5-liter bioreactor samples,
corresponding to different phases of bacterial growth. Further-
more, a delayed stationary phase associated with the scale-up pro-
cess is clearly evident (Fig. 2, 120 to 168 h), which is in agreement
with the turbidimetric findings (Fig. 1).
The PC-DFA scores of the samples grown from 0 to 48 h were
plotted separately in order to investigate further the effects of the
scale-up on the lag phase (Fig. 3). While data from both sets of
samples displayed a gradual change, samples from the first 24 h of
incubation showed a clear separation between those from the
100-ml serum bottles and those from the bioreactor (Fig. 3).
The main separation between the two sample sets seems to be
on theDF1 axis. DF1 loading plots (see Fig. S2 in the supplemental
material) were used to identify the most significant variables
(wavenumbers) contributing toward this clustering pattern. Ma-
jor variations within FTIR spectra for the lag and log phases of
both culturing conditions were in the following main regions: (i)
amide I (1,655 cm1) and amide II (1,541 cm1) bands for
proteins, (ii) fatty acids (2,895 cm1), and (iii) carboxylic acids
(3,046, 1,709, 1,593, 1,402, and 1,223 cm1).
Cells grown in the bioreactor started to proceed from lag
phase and on to log phase after approximately 24 h of incuba-
tion, while those grown in the 100-ml serum bottles completed
this transition within the first 6 h of incubation (Fig. 1). Inter-
estingly, the PC-DFA score plot (Fig. 3) displayed the cluster-
ing of spectra from bioreactor-grown cells up to the first 24 h of
incubation on the negative side of DF1 (red dashed cluster).
The only spectra from the serum bottles clustering on the same
side are from those samples taken within the first 6 h of incu-
bation (green dashed cluster). Moreover, spectra from the bio-
reactor samples taken after 24 h of incubation display the oc-
currence of a phenotypic change by moving toward the serum
bottle samples (Fig. 3, blue dashed cluster), which according to
the growth curve (Fig. 1) coincides with the end of the lag phase
and start of the log phase.
In summary, the FTIR results were consistent with the growth
profiles recorded for both sets of samples, showing phenotypic
changes that coincided with the occurrence of an extended lag
phase during the scale-up process. To explore the accompanying
FIG 2 PC-DFA score plot of the FTIR data collected for all the samples. Five PCs with a total explained variance of 97.39% were used for the DFA. The two sets
of samples, i.e., the 100-ml serumbottles (circles) and the bioreactor (crosses), displayed similar growth patterns.However, compared to cells grown in the serum
bottles, the bioreactor-grown cells displayed an extended lag phase (up to24 h) and consequently entered the stationary phase at a later time point. The arrows
illustrate the main trajectories with respect to time. The color bar on the right represents the duration of the incubation during which samples were collected.
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phenotypic changes inmore detail, we employed the complemen-
tary tool of the metabolic profiling approach using GC-MS.
GC-MS metabolic profiling. In order to elucidate further the
general metabolic changes occurring within and between clusters
from the entire sample set, a PC-DFA score plot of the GC-MS
data collected for all the samples was constructed (using the first
10 PCs with a total explained variance of 96.7%, with a priori
groups being the individual time points) (Fig. 4a).
The PC-DFA score plot (Fig. 4a) of the cell extracts displayed a
trajectory similar to that seen in the FTIR data (Fig. 3), showing
the segregation of different growth phases and the transition of
these distinct physiological states through the connecting time
points. Furthermore, these results point to a gradual change oc-
curring between the cells grown in the bioreactor and serum bot-
tles after the first 6 h of incubation. This gradual change coincides
with the transition from lag to log phase (Fig. 1) for the cells grown
in the serum bottles, while the bioreactor-grown cells remained in
the lag phase at these time points.
The bioreactor samples displayed a clear change of trajectory
after the 24-h time point (Fig. 4a), clustering closer toward the
serum bottle samples corresponding to the end of lag phase and
start of log phase (Fig. 1). Since a significant metabolic difference
was observed in the PC-DFA of the complete data set, these data
were explored in more depth using CCA.
Similar to the PC-DFA, CCA was conducted on the PC scores
of the first 10 PCs to investigate the correlation between the rela-
tive peak intensities of differentmetabolites with incubation time.
Overall, these results (Fig. 4b) display a clear linear time-depen-
dent effect with a canonical correlation coefficient of 0.9439, in-
dicating a strong correlation between the GC-MS profiles and the
incubation time. With the exception of the first time point (this is
likely to be related to the lag phase), the 100-ml serum bottle
samples displayed a positive correlation with incubation time. In
contrast, the bioreactor samples displayed a negative correlation
with time for samples collected in the first 24 h, followed by the
same positive trend as for the 100-ml serum bottles. Furthermore,
both sets of samples (bioreactor and serum bottles) seem to pass
through an overlapping period after a 96-h of incubation period.
The CCA findings from the GC-MS data were in agreement with
the PC-DFA score plots of the FTIR (Fig. 2 and 3) andGC-MSdata
(Fig. 4a), as well as the growth curves (Fig. 1), coinciding with the
occurrence of an extended lag phase for the bioreactor-grown cells
associated with the scale-up process.
The CCA loading plot (Fig. 5) indicates the most significant
variables (metabolites) that were positively or negatively corre-
lated with incubation time. The plot illustrates that the most sig-
nificant variables that were negatively correlated with time were
fumarate, oxaloacetate, and an unknownmetabolite (variable 59),
while citrate shows a strong positive correlation (a full list of iden-
tified metabolites can be found in Table S2 in the supplemental
material). Figure 6 shows the relative peak intensities of the sig-
nificant metabolites selected by CCA and positively identified us-
ing an in-house library (discussed and interpreted below).
Interpretation of GC-MS metabolic profiles. Since acetate is
one of the key intermediate products in anaerobic metabolism of
natural complex organic matter in the sedimentary environment
(3, 4), the ability to take up and utilize this compound efficiently
provides a competitive advantage (67). Studies have shown the
presence of acetate permease-like proteins (68) (Fig. 7, magenta
channel) in G. sulfurreducens, homologues to ActP in Escherichia
coli which are known to be responsible for acetate uptake (69).
The acetate imported by G. sulfurreducens can be activated via
FIG 3 PC-DFA score plot (using 3 PCs with a total explained variance of 96.18%) ofG. sulfurreducens cells grown in 100-ml serum bottles (circles) and a 5-liter
bioreactor (crosses) between 0 and 48 h of incubation at 30°C. There is a clear separation between the two different sets of samples on the basis of DF1 in the first
24 h of incubation. The color bar on the right represents the duration of the incubation during which samples were collected.
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ligationwith coenzymeA (CoA) through twomain pathways (70).
The first of these pathways involves the oxidation of acetate
through the conversion of succinyl-CoA to succinate via the ac-
tivity of the succinyl-CoA:acetate CoA-transferase enzyme (EC
2.8.3.18) (Fig. 7, yellow arrow). Acetyl-CoA produced via this
pathway is directed toward the citrate synthase reaction in the
tricarboxylic acid (TCA) cycle (70).
The second pathway involves the phosphorylation of acetate
via acetate kinase (EC 2.7.2.1) followed by a second reaction in-
volving phosphotransacetylase (EC 2.3.1.8) converting acetyl-
phosphate to acetyl-CoA (Fig. 7, purple arrows) (70, 71). The
acetyl-CoA produced via this pathway is converted to pyruvate via
the activity of pyruvate oxidoreductase (EC 1.2.7.1) operating in
the reverse direction (Fig. 7, purple arrow) (1). The reduced ferre-
doxin produced via the TCA cycle provides the reducing power to
enable this reaction (Fig. 7, dashed blue arrow).
The fumarate provided in the medium as an electron acceptor
is taken up by the cells via a C4-dicarboxylic acid transporter pro-
tein (Fig. 7, red transporter channel) (72), followed by its conver-
sion to succinate either via a reducing reaction catalyzed by the
membrane-bound fumarate reductase (EC 1.3.5.4) (Fig. 7,
FrdCAB enzyme) or via the TCA cycle (Fig. 7, blue arrows) (71, 72).
The GC-MS results show an accumulation of fumarate (Fig.
6a) during the lag phase followed by a gradual depletion in intra-
cellular levels throughout the following time points in both bio-
reactor- and 100-ml serum bottle-grown cells. This accumulation
of fumarate reaches its peak point at around 24 h for the bioreac-
tor samples and at around 6 h of incubation for the 100-ml serum
bottle samples, followed by a decreasing trend corresponding to
the consumption of fumarate by the cells and the transition from
lag to log phase in both batch cultures (Fig. 1). A possible reason
for accumulation of fumarate could be linked to its high concen-
tration in the medium, resulting in cells adjusting to their new
environment by importing fumarate.
Yang and coworkers (73) suggested the potential use of fuma-
rate as a carbon source and its contribution to gluconeogenesis
through its conversion to malate by fumarase and further to oxa-
loacetate via malate dehydrogenase (MDH) (EC 1.1.1.37). These
authors also suggested that around 90 to 95% of the oxaloacetate
produced via this pathway is directed toward gluconeogenesis and
pyruvate production, via its conversion to phosphoenolpyruvate
through the activity of phosphoenolpyruvate carboxykinase (EC
4.1.1.32) (Fig. 7, orange arrows).
The levels of oxaloacetate detected in our study supported
these findings, as the 100-ml serum bottle samples showed a
higher intensity of oxaloacetate (approximately double) than de-
tected in the bioreactor samples during the first 24 h of incubation
(Fig. 6c). This coincides with the consumption of fumarate (Fig.
6a) and an increase in pyruvate levels (Fig. 6e) for the 100-ml
serum bottle samples, while there was an accumulation of fuma-
rate (Fig. 6a) and no change in the pyruvate levels (Fig. 6e) in the
bioreactor samples. These findings further highlight the potential
role of fumarate as a carbon source, as stated by Yang et al. (73)
and discussed above, through its conversion to oxaloacetate via
the TCA cycle and the contribution of produced oxaloacetate to-
ward gluconeogenesis (Fig. 7, orange arrows), resulting in higher
pyruvate levels for biomass and amino acid biosynthesis.
FIG 4 (a) PC-DFA score plot of the G. sulfurreducens cell extracts analyzed
using GC-MS from 100-ml serum bottles (stars) and a 5-liter bioreactor (cir-
cles), collected from all time points. (b) CCA plot against time of the relative
peak areas of detected metabolites by GC-MS for 100-ml serum bottle (stars)
and bioreactor (circles) samples. Both samples displayed an overall linear
time-dependent correlation. The color bars on the right represent the duration
of the incubation during which samples were collected.
FIG 5 CCA loading plot of all the sample extracts analyzed by GC-MS, show-
ing themost significant metabolites contributing toward the positive and neg-
ative correlation with time throughout the data set. The list of identified me-
tabolites can be found in Table S2 in the supplemental material. Fumarate is
seen as three peaks, as different derivatization products are seen in GC-MS.
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FIG6 RelativeGC-MSpeak intensities of significantmetabolites between100-ml serumbottle (stars) andbioreactor (circles) cell extracts during the incubationperiod.
The color bars on the right represent the duration of the incubation during which samples were collected.
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It is known that conversion ofmalate to oxaloacetate viaMDH
activity is thermodynamically unfavorable in cells (74). This may
constrain oxaloacetate homeostasis in cells grown with fumarate
as the electron acceptor, while resulting in accumulation of
malate, which could eventually be secreted into the medium (71).
The GC-MS data confirm these findings, as malate levels were
not overly affected by the scaling-up process, since its intensities
were similar in both bioreactor- and 100-ml serum bottle-grown
cells throughout the experiments (Fig. 6b).
Nicotinamide was also identified by the CCA (Fig. 5; see Table
S2 in the supplemental material). NAD is a cofactor involved in
more than 300 oxidation-reduction reactions, of which the con-
version of malate to oxaloacetate through the activity of MDH is
one (75). The nicotinamide levels may reflect the levels of NAD
availability within cells at different stages of growth. Interestingly,
the levels of nicotinamide under both cultivation conditions dis-
played trends very similar to those of oxaloacetate and pyruvate,
starting at low concentrations during the lag phase, increasing
throughout the log phase, and finishing with a period of stability
during the stationary phase (Fig. 6h).
The lower availability of NAD during the lag phase of cells
grown in the bioreactor may affect the respiration rate by limiting
the activity of MDH, an NAD-dependent enzyme, resulting in
lower oxaloacetate formation. This may trigger a feedback loop
which could be explained as follows: first, it limits the amount of
oxaloacetate which could be fed into gluconeogenesis, pyruvate
synthesis, and acetyl-CoA production (Fig. 7, orange arrows); sec-
ond, it reduces the respiration rate, which is followed by subse-
quent limitation of the 2-oxoglutarate availability and its conver-
sion to succinyl-CoA, which provides the reduced ferredoxin (Fig.
7, dashed blue arrow) required for catalyzing the conversion of
acetyl-CoA to pyruvate (Fig. 7, purple arrow).
Furthermore, intracellular citrate levels in the 100-ml serum
bottles started to increase after the first 6 h of incubation up to the
96-h time point, followed by a decreasing trend (Fig. 6d, stars). By
contrast, citrate levels in the bioreactor samples were low and
stable up to the first 24 h of incubation, after which they followed
the same trend as in the serum bottle samples (Fig. 6d, circles).
These findings further support our hypothesis that limited MDH
activity restricts the pool of oxaloacetate, resulting in lower activ-
ity of the TCA cycle during the lag phase for G. sulfurreducens
grown under both cultivation conditions.
To test the above hypothesis, NBAF was supplemented with
nicotinamide (final concentration of 1 mM) to investigate the
effects of nicotinamide on the growth of G. sulfurreducens cells in
the 5-liter bioreactor. The growth curves displayed in Fig. 1 sug-
FIG 7 Pathway of acetate metabolism in G. sulfurreducens during growth on NBAF medium with fumarate as the electron acceptor and acetate as the electron
donor. Acetate is transported into the cells (green arrow) via acetate permease (magenta protein channel). Imported acetate can be activated via one of the
following two pathways: (i) the acetate kinase (EC 2.7.2.1) followed by the activity of phosphotransacetylase enzyme (EC 2.3.1.8) (purple arrows) producing
acetyl-CoAwhich is directed toward pyruvate synthesis and subsequently into biomass and amino acid synthesis pathways, or (ii) acetate being oxidized through
conversion of succinyl-CoA to succinate via the activity of succinyl-CoA:acetate CoA-transferase enzyme (EC2.8.3.18), resulting in the production of acetyl-CoA
(yellow arrows) which is directed toward the TCA cycle. The fumarate provided in the medium is taken up (green arrow) via the fumarate transporter proteins
(C4-dicarboxylic acid transporter). Imported fumarate can either be (i) directed toward theTCAcycle (blue arrow),which operates as an open loop and endswith
the formation of succinate and its excretion into themedium (red arrow), or (ii) reduced to succinate via the activity of innermembrane-bound FrdCAB enzyme
(fumarate reductase activity) followed by its excretion into the medium (red arrow) (66, 67, 76, 77).
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gest that the nicotinamide-supplemented NBAF significantly im-
proved the growth of the cells in the 5-liter bioreactor, while re-
ducing the lag phase period from 24 h to 6 h, similar to that of the
cells grown in the 100-ml serum bottles. Furthermore, levels of
nicotinamide in the medium detected by GC-MS analysis (Fig. 1)
show the consumption of nicotinamide. TheNBAFmediumprior
to nicotinamide supplementation was also tested by GC-MS anal-
ysis; however, as expected, no peaks corresponding to nicotin-
amide were detected (data not shown). The nicotinamide supple-
mentation effect on growth is illustrated in Fig. 1. As nicotinamide
starts a depletion trend (60 h), the growth rate is declining and
cells enter stationary phase. This is followed be the complete de-
pletion of nicotinamide in the medium (96 h), which is concom-
itant with a steady period of growth.
We also examined the growth behavior of G. sulfurreducens on
NBAF supplemented with nicotinamide (1mM) and oxaloacetate
(6 mM) in the 100-ml serum bottles; while oxaloacetate supple-
mentation resulted in an extended lag phase, nicotinamide had no
significant effects on the lag phase (see Fig. S4 in the supplemental
material).
On the whole, during the first 24 h of incubation, the majority of
themetabolites detecteddisplayed lower intensities in thebioreactor-
grown cells than in those grown in the 100-ml serum bottles, espe-
cially metabolites of TCA cycle, with the exception of malate and
fumarate (Fig. 6). Comparisons of the significant FTIR vibrations
(Fig. 8; see Fig. S3 in the supplemental material), identified via PC-
DFA loadings (see Fig. S2), were in agreement with theGC-MSfind-
ings (Fig. 6). The intensity of the amide I band (Fig. 8a) for the serum
bottle samples showed an increasing trend up to the first 24 h fol-
lowed by a steady state, while the bioreactor samples displayed no
significant change up to the 24-h time point followed by a slow in-
crease thereafter. Furthermore, comparison of the intensity of car-
boxylic acid-specific FTIR vibrations (Fig. 8b; see Fig. S3) for the
bioreactor samples also displayed a similar trend, with a steady state
in the first 24 h followed by a slow increase, while the intensities
detected for the serumbottle sampleswerealmost6 timeshigher than
those for the bioreactor samples.
Finally, the concentrations of glycerol-3-phosphate (Fig. 6f)
did not change during the lag phase but increased sharply during
the exponential phase, before finally reaching a period of stability
during the stationary phase under both culturing conditions. This
is of course perhaps not surprising, as glycerol-3-phosphate is one
of themain precursors for the synthesis of triacylglycerides, which
are major lipid components of bacterial cell membranes. There-
fore, the concentration and necessity of this compound are di-
rectly related to the bacterial growth rate, which is in complete
agreement with our GC-MS findings.
Concluding remarks.This study clearly demonstrates the effects
of scale-up on the growth and metabolism of G. sulfurreducens
grown onNBAFwith acetate as an electron donor and fumarate as
an electron acceptor in batch culture. It also illustrates some of the
challenges involved with scaling up bioprocesses, which is vital to
underpin biotechnological exploitation of a wide range of micro-
organisms, including Geobacter species. The FTIR findings em-
phasize the advantages of this technique as a rapid, nondestruc-
tive, relatively inexpensive, and high-throughput screening tool
and also reveal its potential for applications in a wide range of
areas, including industrial scale-up. Our GC-MS metabolic pro-
filing results suggested that the limited availability of oxaloacetate,
potentially due to restricted nicotinamide levels andmalate dehy-
drogenase activity, could be a significantmetabolicbottleneckresult-
ing from this scale-up process. Additional metabolomics experiments
were performed to test this hypothesis. Guided by the hypothesis gener-
ation experiments fromGC-MS (shown schematically in Fig. S5 in the
supplementalmaterial),which suggested that cellsmaybe starvedof ox-
aloacetate and/or nicotinamide, further cultures were grown that were
supplementedwith thesemetabolic intermediates to test these hypothe-
ses(seeFig.S5).Whilesupplementationwithoxaloacetatehadanegative
effect on growth, when nicotinamidewas added at the start of culturing
in thebioreactor, thebacterial lagphasewas significantly shorter andat a
level comparable to that detected in the 100-ml serumbottles.
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FIG 8 Comparison of the intensities of significant FTIR vibrations identified
by the PC-DFA loading plot of serum bottle (stars) and bioreactor (circles)
samples during the first 48 h of incubation (see Fig. S2 in the supplemental
material). (a) The 1,655 cm1 amide I region due to stretching of CObonds;
(b) the 1,402 cm1 region due to symmetric stretching of CO bonds in
carboxylic acids. Data points represent the mean of the three replicates, with
bars indicating the relative standard deviation. The color bars on the right
represent the duration of the incubation during which samples were collected.
Muhamadali et al.
3296 aem.asm.org May 2015 Volume 81 Number 10Applied and Environmental Microbiology
 o
n
 February 7, 2017 by UNIV O
F SALFO
RD
http://aem
.asm
.org/
D
ow
nloaded from
 
REFERENCES
1. Mahadevan R, Palsson BO, Lovley DR. 2011. In situ to in silico and back:
elucidating the physiology and ecology of Geobacter spp. using genome-
scale modelling. Nat Rev Microbiol 9:39–50. http://dx.doi.org/10.1038
/nrmicro2456.
2. Methe BA, Nelson KE, Eisen JA, Paulsen IT, Nelson W, Heidelberg JF,
Wu D, Wu M, Ward N, Beanan MJ, Dodson RJ, Madupu R, Brinkac
LM, Daugherty SC, DeBoy RT, Durkin AS, Gwinn M, Kolonay JF,
Sullivan SA, Haft DH, Selengut J, Davidsen TM, Zafar N, White O,
Tran B, Romero C, Forberger HA, Weidman J, Khouri H, Feldblyum
TV, Utterback TR, Van Aken SE, Lovley DR, Fraser CM. 2003. Genome
of Geobacter sulfurreducens: metal reduction in subsurface environments.
Science 302:1967–1969. http://dx.doi.org/10.1126/science.1088727.
3. Lovley DR. 1995. Bioremediation of organic and metal contaminants
with dissimilatory metal reduction. J Ind Microbiol 14:85–93. http://dx
.doi.org/10.1007/BF01569889.
4. Lovley DR. 2002. Dissimilatory metal reduction: from early life to biore-
mediation. ASM News 68:231–237.
5. Lovley DR, Stolz JF, Nord GL, Phillips EJP. 1987. Anaerobic production
of magnetite by a dissimilatory iron-reducing microorganism. Nature
330:252–254. http://dx.doi.org/10.1038/330252a0.
6. Lovley DR, Phillips EJ. 1988. Novel mode of microbial energy metabo-
lism: organic carbon oxidation coupled to dissimilatory reduction of iron
or manganese. Appl Environ Microbiol 54:1472–1480.
7. Caccavo F, Lonergan DJ, Lovley DR, Davis M, Stolz JF, McInerney MJ.
1994.Geobacter sulfurreducens sp. nov., a hydrogen- and acetate-oxidizing
dissimilatory metal-reducing microorganism. Appl Environ Microbiol
60:3752–3759.
8. Lin WC, Coppi MV, Lovley DR. 2004. Geobacter sulfurreducens can grow
with oxygen as a terminal electron acceptor. Appl Environ Microbiol 70:
2525–2528. http://dx.doi.org/10.1128/AEM.70.4.2525-2528.2004.
9. Lovley DR, Holmes DE, Nevin KP. 2004. Dissimilatory Fe(III) and
Mn(IV) reduction. Adv Microb Physiol 49:219–286. http://dx.doi.org/10
.1016/S0065-2911(04)49005-5.
10. Lovley DR, Anderson RT. 2000. Influence of dissimilatory metal reduc-
tion on fate of organic and metal contaminants in the subsurface. Hydro-
geology J 8:77–88. http://dx.doi.org/10.1007/PL00010974.
11. Lloyd JR, Lovley DR. 2001. Microbial detoxification of metals and radio-
nuclides. Curr Opin Biotechnol 12:248–253. http://dx.doi.org/10.1016
/S0958-1669(00)00207-X.
12. Finneran KT, Anderson RT, Nevin KP, Lovley DR. 2002. Potential for
bioremediation of uranium-contaminated aquifers with microbial U(VI)
reduction. Soil Sed Contam 11:339–357. http://dx.doi.org/10.1080
/20025891106781.
13. Lovley DR, Phillips EJP, Gorby YA, Landa ER. 1991.Microbial reduction of
uranium. Nature 350:413–416. http://dx.doi.org/10.1038/350413a0.
14. Telling ND, Coker VS, Cutting RS, van der Laan G, Pearce CI, Pattrick
RAD, Arenholz E, Lloyd JR. 2009. Remediation of Cr(VI) by biogenic
magnetic nanoparticles: an x-ray magnetic circular dichroism study. Ap-
plied Physics Lett 95:163701. http://dx.doi.org/10.1063/1.3249578.
15. Lloyd JR, Sole VA, Van Praagh CVG, Lovley DR. 2000. Direct and
Fe(II)-mediated reduction of technetium by Fe(III)-reducing bacteria.
Appl Environ Microbiol 66:3743–3749. http://dx.doi.org/10.1128/AEM
.66.9.3743-3749.2000.
16. Cui D, Eriksen TE. 1996. Reduction of pertechnetate in solution by
heterogeneous electron transfer from Fe(II)-containing geological mate-
rial. Environ Sci Technol 30:2263–2269. http://dx.doi.org/10.1021
/es950627v.
17. Lloyd JR. 2003. Microbial reduction of metals and radionuclides. FEMSMi-
crobiologyRev 27:411–425. http://dx.doi.org/10.1016/S0168-6445(03)00044-5.
18. Williams KH, Bargar JR, Lloyd JR, Lovley DR. 2013. Bioremediation of
uranium-contaminated groundwater: a systems approach to subsurface
biogeochemistry. CurrOpinBiotechnol 24:489–497. http://dx.doi.org/10
.1016/j.copbio.2012.10.008.
19. Byrne JM, Telling ND, Coker VS, Pattrick RAD, van der Laan G,
Arenholz E, Tuna F, Lloyd JR. 2011. Control of nanoparticle size, reac-
tivity and magnetic properties during the bioproduction of magnetite by
Geobacter sulfurreducens. Nanotechnology 22:455709. http://dx.doi.org
/10.1088/0957-4484/22/45/455709.
20. Coker V, Pattrick R, van der Laan G, Lloyd J. 2007. Formation of
magneticminerals by non-magnetotactic prokaryotes.MicrobiolMonogr
3:275–300. http://dx.doi.org/10.1007/7171_047.
21. Cutting RS, Coker VS, Fellowes JW, Lloyd JR, Vaughan DJ. 2009.
Mineralogical and morphological constraints on the reduction of Fe(III)
minerals by Geobacter sulfurreducens. Geochim Cosmochim Acta 73:
4004–4022. http://dx.doi.org/10.1016/j.gca.2009.04.009.
22. Prijic S, Sersa G. 2011. Magnetic nanoparticles as targeted delivery sys-
tems in oncology. Radiol Oncol 45:1–16. http://dx.doi.org/10.2478
/v10019-011-0001-z.
23. Majewskia P, Thierrya B. 2007. Functionalized magnetite nanopar-
ticles—synthesis, properties, and bio-applications. Crit Rev Solid State
Mat Sci 32:203–215. http://dx.doi.org/10.1080/10408430701776680.
24. Franzreb M, Siemann-Herzberg M, Hobley T, Thomas O. 2006. Protein
purification using magnetic adsorbent particles. Appl Microbiol Biotech-
nol 70:505–516. http://dx.doi.org/10.1007/s00253-006-0344-3.
25. Berensmeier S. 2006. Magnetic particles for the separation and purifica-
tion of nucleic acids. ApplMicrobiol Biotechnol 73:495–504. http://dx.doi
.org/10.1007/s00253-006-0675-0.
26. Coker VS, Bennett JA, Telling ND, Henkel T, Charnock JM, van der Laan
G, Pattrick RA, Pearce CI, Cutting RS, Shannon IJ, Wood J, Arenholz E,
Lyon IC, Lloyd JR. 2010. Microbial engineering of nanoheterostructures:
biological synthesis of a magnetically recoverable palladium nanocatalyst.
ACS Nano 4:2577–2584. http://dx.doi.org/10.1021/nn9017944.
27. Reference deleted.
28. Zeng H, Black CT, Sandstrom RL, Rice PM, Murray CB, Sun S. 2006.
Magnetotransport of magnetite nanoparticle arrays. Phys Rev B 73:
020402. http://dx.doi.org/10.1103/PhysRevB.73.020402.
29. Bundy J, Davey M, Viant M. 2009. Environmental metabolomics: a
critical review and future perspectives. Metabolomics 5:3–21. http://dx
.doi.org/10.1007/s11306-008-0152-0.
30. FiehnO. 2002.Metabolomics—the link between genotypes and phenotypes.
PlantMol Biol 48:155–171. http://dx.doi.org/10.1023/A:1013713905833.
31. Ellis DI, Dunn WB, Griffin JL, Allwood JW, Goodacre R. 2007. Meta-
bolic fingerprinting as a diagnostic tool. Pharmacogenomics 8:1243–1266.
http://dx.doi.org/10.2217/14622416.8.9.1243.
32. Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, Walsh
MC, Berden JA, Brindle KM, Kell DB, Rowland JJ, Westerhoff HV, van
Dam K, Oliver SG. 2001. A functional genomics strategy that uses
metabolome data to reveal the phenotype of silent mutations. Nat Bio-
technol 19:45–50. http://dx.doi.org/10.1038/83496.
33. Urbanczyk-Wochniak E, Luedemann A, Kopka J, Selbig J, Roessner-
Tunali U, Willmitzer L, Fernie AR. 2003. Parallel analysis of transcript
and metabolic profiles: a new approach in systems biology. EMBO Rep
4:989–993. http://dx.doi.org/10.1038/sj.embor.embor944.
34. Ellis DI, Goodacre R. 2012. Metabolomics-assisted synthetic biology. Curr
Opin Biotechnol 23:22–28. http://dx.doi.org/10.1016/j.copbio.2011.10.014.
35. van der Werf MJ, Overkamp KM, Muilwijk B, Coulier L, Hankemeier
T. 2007. Microbial metabolomics: toward a platform with full metabo-
lome coverage. Anal Biochem 370:17–25. http://dx.doi.org/10.1016/j.ab
.2007.07.022.
36. Winder CL, Dunn WB, Goodacre R. 2011. TARDIS-based microbial
metabolomics: time and relative differences in systems. Trends Microbiol
19:315–322. http://dx.doi.org/10.1016/j.tim.2011.05.004.
37. Al-Qadiri HM, Al-Alami NI, Lin M, Al-Holy M, Cavinato AG, Rasco BA.
2008. Studying of the bacterial growth phases using Fourier transform infra-
red spectroscopy andmultivariate analysis. JRapidMethodsAutomatMicro-
biol 16:73–89. http://dx.doi.org/10.1111/j.1745-4581.2008.00117.x.
38. Mamas M, Dunn WB, Neyses L, Goodacre R. 2011. The role of metab-
olites and metabolomics in clinically applicable biomarkers of disease.
Arch Toxicol 85:5–17. http://dx.doi.org/10.1007/s00204-010-0609-6.
39. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. 2011.
Systems level studies of mammalian metabolomes: the roles of mass spec-
trometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev
40:387–426. http://dx.doi.org/10.1039/B906712B.
40. Naumann D, Helm D, Labischinski H. 1991. Microbial characterizations
by FTIR spectroscopy. Nature 351:81–82. http://dx.doi.org/10.1038
/351081a0.
41. AlRabiah H, Correa E, Upton M, Goodacre R. 2013. High-throughput
phenotyping of uropathogenic E. coli isolates with Fourier transform in-
frared spectroscopy. Analyst 138:1363–1369. http://dx.doi.org/10.1039
/c3an36517d.
42. Fischer G, Braun S, Thissen R, DottW. 2006. FTIR spectroscopy as a tool
for rapid identification and intra-species characterization of airborne fil-
amentous fungi. J Microbiol Methods 64:63–77. http://dx.doi.org/10
.1016/j.mimet.2005.04.005.
Metabolic Proﬁling of G. sulfurreducens Scale-Up
May 2015 Volume 81 Number 10 aem.asm.org 3297Applied and Environmental Microbiology
 o
n
 February 7, 2017 by UNIV O
F SALFO
RD
http://aem
.asm
.org/
D
ow
nloaded from
 
43. Ellis DI, Brewster VL, Dunn WB, Allwood JW, Golovanov AP, Gooda-
cre R. 2012. Fingerprinting food: current technologies for the detection of
food adulteration and contamination. Chem Soc Rev 41:5706–5727. http:
//dx.doi.org/10.1039/c2cs35138b.
44. Ellis DI, Broadhurst D, Kell DB, Rowland JJ, Goodacre R. 2002. Rapid and
quantitative detection of themicrobial spoilage ofmeat by Fourier transform
infrared spectroscopy and machine learning. Appl Environ Microbiol 68:
2822–2828. http://dx.doi.org/10.1128/AEM.68.6.2822-2828.2002.
45. Roussel S, Bellon-Maurel W, Roger JM, Grenier P. 2003. Authenticating
white grape must variety with classification models based on aroma sen-
sors, FTIR and UV spectrometry. J Food Eng 60:407–419. http://dx.doi
.org/10.1016/S0260-8774(03)00064-5.
46. Wang H, Hollywood K, Jarvis RM, Lloyd JR, Goodacre R. 2010. Pheno-
typic characterization of Shewanella oneidensis MR-1 under aerobic and
anaerobic growth conditions by using Fourier transform infrared spec-
troscopy and high-performance liquid chromatography analyses. Appl
EnvironMicrobiol 76:6266–6276. http://dx.doi.org/10.1128/AEM.00912-10
.
47. Wharfe ES, Jarvis RM, Winder CL, Whiteley AS, Goodacre R. 2010.
Fourier transform infrared spectroscopy as a metabolite fingerprinting
tool formonitoring the phenotypic changes in complex bacterial commu-
nities capable of degrading phenol. Environ Microbiol 12:3253–3263.
http://dx.doi.org/10.1111/j.1462-2920.2010.02300.x.
48. Filip Z, Hermann S. 2001. An attempt to differentiate Pseudomonas spp.
and other soil bacteria by FTIR spectroscopy. Eur J Soil Biol 37:137–143.
http://dx.doi.org/10.1016/S1164-5563(01)01078-0.
49. Pan J, Ge X, Liu R, Tang H. 2006. Characteristic features of Bacillus
cereus cell surfaces with biosorption of Pb(II) ions by AFM and FTIR.
Colloids Surf B Biointerfaces 52:89–95. http://dx.doi.org/10.1016/j
.colsurfb.2006.05.016.
50. Correa E, Sletta H, Ellis DI, Hoel S, Ertesvag H, Ellingsen TE, Valla S,
Goodacre R. 2012. Rapid reagentless quantification of alginate biosynthe-
sis in Pseudomonas fluorescens bacteria mutants using FTIR spectroscopy
coupled to multivariate partial least squares regression. Anal Bioanal
Chem 403:2591–2599. http://dx.doi.org/10.1007/s00216-012-6068-6.
51. Fischer E, Sauer U. 2003. Metabolic flux profiling of Escherichia coli
mutants in central carbon metabolism using GC-MS. Eur J Biochem 270:
880–891. http://dx.doi.org/10.1046/j.1432-1033.2003.03448.x.
52. Cutting RS, Coker VS, Telling ND, Kimber RL, Pearce CI, Ellis BL,
Lawson RS, van der Laan G, Pattrick RAD, Vaughan DJ, Arenholz E,
Lloyd JR. 2010. Optimizing Cr(VI) and Tc(VII) remediation through
nanoscale biomineral engineering. Environ Sci Technol 44:2577–2584.
http://dx.doi.org/10.1021/es902119u.
53. Lovley DR, Phillips EJ. 1986. Availability of ferric iron for microbial
reduction in bottom sediments of the freshwater tidal Potomac river. Appl
Environ Microbiol 52:751–757.
54. Winder CL, Gordon SV, Dale J, Hewinson RG, Goodacre R. 2006.
Metabolic fingerprints of Mycobacterium bovis cluster with molecular
type: implications for genotype-phenotype links.Microbiology 152:2757–
2765. http://dx.doi.org/10.1099/mic.0.28986-0.
55. Martens H, Nielsen JP, Engelsen SB. 2003. Light scattering and light
absorbance separated by extendedmultiplicative signal correction. Appli-
cation to near-infrared transmission analysis of powder mixtures. Anal
Chem 75:394–404. http://dx.doi.org/10.1021/ac020194w.
56. Wold S, Esbensen K, Geladi P. 1987. Principal component analysis.
Chemometrics Intelligent Lab Syst 2:37–52. http://dx.doi.org/10.1016
/0169-7439(87)80084-9.
57. Macfie HJH, Gutteridge CS, Norris JR. 1978. Use of canonical variates
analysis in differentiation of bacteria by pyrolysis gas-liquid chromatog-
raphy. J Gen Microbiol 104:67–74. http://dx.doi.org/10.1099/00221287
-104-1-67.
58. Winder CL, Dunn WB, Schuler S, Broadhurst D, Jarvis R, Stephens
GM, Goodacre R. 2008. Global metabolic profiling of Escherichia coli
cultures: an evaluation of methods for quenching and extraction of intra-
cellular metabolites. Anal Chem 80:2939–2948. http://dx.doi.org/10.1021
/ac7023409.
59. Fiehn O, Wohlgemuth G, Scholz M, Kind T, Lee DY, Lu Y, Moon S,
Nikolau B. 2008. Quality control for plant metabolomics: reporting MSI-
compliant studies. Plant J 53:691–704. http://dx.doi.org/10.1111/j.1365
-313X.2007.03387.x.
60. Wedge DC, Allwood JW, Dunn W, Vaughan AA, Simpson K, Brown M,
Priest L, Blackhall FH, Whetton AD, Dive C, Goodacre R. 2011. Is
serum or plasma more appropriate for intersubject comparisons in
metabolomic studies? An assessment in patients with small-cell lung can-
cer. Anal Chem 83:6689–6697. http://dx.doi.org/10.1021/ac2012224.
61. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S,
Anderson N, Brown M, Knowles JD, Halsall A, Haselden JN, Nicholls
AW, Wilson ID, Kell DB, Goodacre R, The Human Serum Metabolome
(HUSERMET) Consortium. 2011. Procedures for large-scale metabolic
profiling of serum and plasma using gas chromatography and liquid chro-
matography coupled to mass spectrometry. Nat Protoc 6:1060–1083.
http://dx.doi.org/10.1038/nprot.2011.335.
62. Begley P, Francis-McIntyre S, Dunn WB, Broadhurst DI, Halsall A,
Tseng A, Knowles J, HUSERMET Consortium, Goodacre R, Kell DB.
2009. Development and performance of a gas chromatography-time-of-
flightmass spectrometry analysis for large-scale nontargetedmetabolomic
studies of human serum. Anal Chem 81:7038–7046. http://dx.doi.org/10
.1021/ac9011599.
63. Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, Fan
TWM, Fiehn O, Goodacre R, Griffin JL, Hankemeier T, Hardy N,
Harnly J, Higashi R, Kopka J, Lane AN, Lindon JC, Marriott P, Nicholls
AW, Reily MD, Thaden JJ, Viant MR. 2007. Proposed minimum report-
ing standards for chemical analysis. Metabolomics 3:211–221. http://dx
.doi.org/10.1007/s11306-007-0082-2.
64. Gromski PS, Xu Y, Kotze HL, Correa E, Ellis DI, Armitage EG, Turner
ML, Goodacre R. 2014. Influence of missing values substitutes on multi-
variate analysis of metabolomics data. Metabolites 4:433–452. http://dx
.doi.org/10.3390/metabo4020433.
65. Härdle WK, Simar L. 2007. Applied multivariate statistical analysis.
Springer, Berlin, Germany.
66. Brown M, Dunn WB, Ellis DI, Goodacre R, Handl J, Knowles JD,
O’Hagan S, Spasic´ I, Kell DB. 2005. A metabolome pipeline: from con-
cept to data to knowledge. Metabolomics 1:39–51. http://dx.doi.org/10
.1007/s11306-005-1106-4.
67. Mahadevan R, Bond DR, Butler JE, Esteve-Nuñez A, Coppi MV,
Palsson BO, Schilling CH, Lovley DR. 2006. Characterization of metab-
olism in the Fe(III)-reducing organism Geobacter sulfurreducens by con-
straint-basedmodeling. Appl EnvironMicrobiol 72:1558–1568. http://dx
.doi.org/10.1128/AEM.72.2.1558-1568.2006.
68. Risso C, Van Dien SJ, Orloff A, Lovley DR, Coppi MV. 2008. Elucidation
of an alternate isoleucine biosynthesis pathway inGeobacter sulfurreducens. J
Bacteriol 190:2266–2274. http://dx.doi.org/10.1128/JB.01841-07.
69. Oh M-K, Rohlin L, Kao KC, Liao JC. 2002. Global expression profiling
of acetate-grown Escherichia coli. J Biol Chem 277:13175–13183. http://dx
.doi.org/10.1074/jbc.M110809200.
70. Segura D, Mahadevan R, Juarez K, Lovley DR. 2008. Computational and
experimental analysis of redundancy in the central metabolism ofGeobac-
ter sulfurreducens. PLoS Comput Biol 4:e36. http://dx.doi.org/10.1371
/journal.pcbi.0040036.
71. Galushko AS, Schink B. 2000. Oxidation of acetate through reactions of
the citric acid cycle by Geobacter sulfurreducens in pure culture and in
syntrophic coculture. Arch Microbiol 174:314–321. http://dx.doi.org/10
.1007/s002030000208.
72. Butler JE, Glaven RH, Esteve-Núñez A, Núñez C, Shelobolina ES, Bond
DR, Lovley DR. 2006. Genetic characterization of a single bifunctional en-
zyme for fumarate reduction and succinate oxidation in Geobacter sulfurre-
ducens and engineering of fumarate reduction in Geobacter metalliredu-
cens. J Bacteriol 188:450–455. http://dx.doi.org/10.1128/JB.188.2.450
-455.2006.
73. Yang TH, Coppi MV, Lovley DR, Sun J. 2010. Metabolic response of
Geobacter sulfurreducens towards electron donor/acceptor variation. Mi-
crob Cell Fact 9:90. http://dx.doi.org/10.1186/1475-2859-9-90.
74. Lehninger AL, Nelson DL, Cox MM. 1993. Principles of biochemistry.
Wiley, New York, NY.
75. Minarik P, Tomaskova N, Kollarova M, Antalik M. 2002. Malate dehy-
drogenases—structure and function. Gen Physiol Biophys 21:257–265.
76. Byrne JM, Coker VS, Moise S, Wincott PL, Vaughan DJ, Tuna F,
Arenholz E, van der Laan G, Pattrick RAD, Lloyd JR, Telling ND. 2013.
Controlled cobalt doping in biogenic magnetite nanoparticles. J R Soc
Interface 10:20130134. http://dx.doi.org/10.1098/rsif.2013.0134.
77. Coker VS, Pearce CI, Pattrick RAD, Van der Laan G, Telling ND,
Charnock JM, Arenholz E, Lloyd JR. 2008. Probing the site occupancies
of Co-, Ni-, and Mn-substituted biogenic magnetite using XAS and
XMCD. Am Mineralog 93:1119–1132. http://dx.doi.org/10.2138/am
.2008.2681.
Muhamadali et al.
3298 aem.asm.org May 2015 Volume 81 Number 10Applied and Environmental Microbiology
 o
n
 February 7, 2017 by UNIV O
F SALFO
RD
http://aem
.asm
.org/
D
ow
nloaded from
 
